Health Economics
Important USPSTF Information – Please Read First
Dear Diagnostic Sales Team:
On April 21st, you received an email from Keith Gantner about the U.S. Preventive Services Task Force (USPSTF) releasing its proposed guidelines on breast cancer screening. Hologic expected this update and is executing on a multi-faceted plan of action to respond.

Shortly, you will receive a customer letter from me that outlines 1) outlines Hologic’s concerns about the USPSTF Proposed Breast Cancer Screening Guidelines 2) urges customers to leverage the Toolkit to make their voices heard before the public comment period ends on May 18th.

Included in the Customer Letter is a link to Hologic’s Online Toolkit we have created to aid customers and patients in USPSTF engagement efforts. The Online Toolkit is informative and easy to use. It provides step-by-step instructions and an array of tools to help customers and patients understand the Proposed Guidelines, prepare and submit clinically-oriented letters to the Task Force efficiently and effectively. We’ve also developed a simple process for customers to share their USPSTF comment letters with Hologic so we can personally deliver them to the Secretary of the Department of Health and Human Services and Members of Congress in Washington, DC. The complete Toolkit can be accessed at the following link:

We’ve also set up a dedicated mailbox ( to which customers can direct their questions and send us copies of their letters.

Once you receive my email with Customer Letter enclosed, please forward it your customers as soon as possible. I urge you to download and review the Toolkit so you can discuss this initiative with your customers and encourage them to act before May 18th. If you have questions, please reach out to your Health Economics manager or simply email, Collectively, we can make a difference.
Meg Eckenroad
Hologic Vice President,
Women's Health and Professional Relations
Keith Gantner
Hologic Senior Vice President,